Welcome to the e-CCO Library!

P440 Polimedication in patients with inflammatory bowel disease: prevalence and outcomes in a retrospective unicentric series
Year: 2020
Source:

ECCO'20 Vienna

Authors:

F. Mesonero Gismero, C. Fernández, E. Sánchez-Rodríguez, A. García-García de Paredes, A. Albillos, A. López-Sanromán

Created: Thursday, 30 January 2020, 10:12 AM
P440: Comparison of infliximab serum levels between venous and capillary blood in paediatric IBD patients using novel blood sampling technology
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Zijlstra*1, M. Jongsma2, A. de Vries3, T. Schaap3, K. Bloem3, L. de Ridder2

Created: Friday, 22 February 2019, 9:41 AM
P440: Early changes in the pharmacokinetic profile of vedolizumab-treated patients with inflammatory bowel disease may predict response after dose optimisation
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Gouynou1, L. Pouillon1,2*, H. Rousseau3, C. Zallot1, C. Baumann3, L. Peyrin-Biroulet1

Created: Thursday, 21 February 2019, 9:14 AM
P440: First results of the BELCOMID study: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID)
Year: 2021
Source: ECCO'21 Virtual
Authors: Geldof, J.(1,2);Truyens, M.(1,2);Sabino, J.(3,4);Ferrante, M.(3,4);Lambert, J.(5);Lapeere, H.(5);Hillary, T.(6);Van Laethem, A.(6);De Vlam, K.(7);Verschueren, P.(7);Lobaton, T.(1,2);Vermeire, S.(3,4);
Created: Wednesday, 2 June 2021, 4:12 PM
P440: Loss of response and dose escalation of infliximab and adalimumab in Ulcerative Colitis patients: A Systematic Review and Meta-analysis.
Year: 2022
Source: ECCO'22
Authors: Savelkoul, E.(1);Thomas, P.(1);Derikx, L.(1);Den Broeder, N.(1);Römkens, T.(2);Hoentjen, F.(3);
Created: Friday, 11 February 2022, 3:52 PM
P440: Prevalence of NUDT15 polymorphisms and incidence of thiopurine-induced leukopenia in Inflammatory Bowel Disease patients: A systematic review and meta-analysis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Yu, N.(1);Sriranganathan, D.(2);Walker, G.J.(3);Sazonovs, A.(4);Wilding, H.(5);Kennedy, N.A.(6,7);Ahmad, T.(6,7);Boyapati, R.K.(8,9);Segal, J.P.(10,11);Ding, N.J.S.(1,11)*;
Created: Friday, 14 July 2023, 11:05 AM
P440: Staged surgical management of complicated ileo-colonic Crohn’s Disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. P. Mishreki*, F. G. Bergin

Created: Friday, 22 February 2019, 9:49 AM
P440: Therapeutic drug monitoring of infliximab for the management of loss of response in inflammatory bowel disease: an observational multicenter study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Pugliese D.*1, Armuzzi A.1, Panici Tonucci T.1, Tolusso B.2, Felice C.1, Papa A.1, Cantoro L.3, Balestrieri P.4, Civitelli F.5, Bertani L.6, Kohn A.3, Cicala M.4, Viola F.5, Costa F.6, Rapaccini G.L.1, Guidi L.1

Created: Wednesday, 20 February 2019, 10:36 AM
P441 Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Ollech1, I. Normatov2, S. Dwadasi2, S. Dalal2, D. Micic2, A. Israel2, J. Labas2, P. Joel2, R. Cohen2, D. Rubin2, S. Atsushi2

Created: Thursday, 30 January 2020, 10:12 AM
P441: Adalimumab versus ustekinumab as first-line biological in a real-life cohort of moderate-to-severe Crohn's disease.
Year: 2022
Source: ECCO'22
Authors: Moens, A.(1);Verstockt, B.(1);Alsoud, D.(2);Sabino, J.(1);Ferrante, M.(1);Vermeire, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P441: Clinical efficacy, drug sustainability and results from therapeutic drug monitoring in Crohn’s disease patients treated with ustekinumab – 1-year follow-up of a prospective, nationwide, multicenter cohort from Hungary
Year: 2021
Source: ECCO'21 Virtual
Authors: Gonczi, L.(1);Szanto, K.(2);Farkas, K.(2);Molnar, T.(2);Szamosi, T.(3);Schafer , E.(3);Golovics, P.(3);Lovasz, B.(1);Patai, A.(4);Vincze, A.(5);Sarlos, P.(5);Farkas, A.(6);Dubrovcsik, Z.(6);Tóth G., T.(7);Lakatos, P.L.(8);Miheller, P.(9);Ilias, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P441: Conjoint analysis for quantification of inflammatory bowel disease patients’ preferences for outcome metrics
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

W. K. van Deen*1, D. Nguyen1, N. Duran1, E. Kane1, M. G. van Oijen2, D.W. Hommes1

Created: Friday, 22 February 2019, 9:49 AM
P441: Higher education, professional occupation and upper socio-economic status is associated with lower adherence to medications in patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

S.K. Tomar1*, S. Kedia2, N. Singh1, A.D. Upadhyay3, S. Bopanna1, D. Yadav1, S. Goyal1, S. Jain1, G. Makharia1, V. Ahuja1

Created: Thursday, 21 February 2019, 9:14 AM
P441: Long-term CD treatment failure and dose modification rates with vedolizumab and other biologics: Results from a large prospective observational study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Siegmund, B.(1)*;Siegel, C.A.(2);Sebastian, S.(3);Zhou, J.(4);Jones, S.(5);Adsul, S.(4);Louis, E.(6);
Created: Friday, 14 July 2023, 11:05 AM
P441: Long-term immunogenicity of vedolizumab in ulcerative colitis and Crohn’s disease (GEMINI Programme)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Wyant1, L. Yang2, R. Lirio2, M. Rosario*2

Created: Friday, 22 February 2019, 9:41 AM
P441: Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Mao R.*1, He Y.1, Ben-Horin S.2, Chen M.-h.1

Created: Wednesday, 20 February 2019, 10:36 AM
P442 Long-term quality of life after surgery for perianal Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

I. Angriman, M. Tomassi, G. Bordignon, R. Bardini, C. Ruffolo, M. Scarpa

Created: Thursday, 30 January 2020, 10:12 AM
P442: Endoscopic resection of visible precancerous lesions in patients with colonic Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Busacca, A.(1)*;De Sire, R.(1);Capogreco, A.(1);Dal Buono, A.(2);Gabbiadini, R.(2);Loy, L.(2);Finati, E.(1);Spadaccini, M.(1);Maselli, R.(1);Hassan, C.(1);Repici, A.(1);Armuzzi, A.(2);
Created: Friday, 14 July 2023, 11:05 AM
P442: Evaluation of safety and efficacy of laparoscopic surgery for ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Yamamoto*, K. Kurachi, T. Harada

Created: Friday, 22 February 2019, 9:49 AM
P442: Incidence of pneumonia and other respiratory tract infections with vedolizumab treatment for inflammatory bowel disease: clinical trial experience
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Feagan B.1, Bhayat F.*2, Khalid J.M.3, Palo W.4, Blake A.5, Shetzline M.6, Travis S.7

Created: Wednesday, 20 February 2019, 10:36 AM